Is GenusPlus Group Ltd's (ASX:GNP) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors' money. Put another way, it reveals the company's success at turning shareholder investments into profits.
AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.
How Do You Calculate Return On Equity?
The formula for return on equity is:
Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity
So, based on the above formula, the ROE for GenusPlus Group is:
17% = AU$24m ÷ AU$137m (Based on the trailing twelve months to December 2024).
The 'return' refers to a company's earnings over the last year. One way to conceptualize this is that for each A$1 of shareholders' capital it has, the company made A$0.17 in profit.
Check out our latest analysis for GenusPlus Group
What Is The Relationship Between ROE And Earnings Growth?
We have already established that ROE serves as an efficient profit-generating gauge for a company's future earnings. We now need to evaluate how much profit the company reinvests or "retains" for future growth which then gives us an idea about the growth potential of the company. Assuming everything else remains unchanged, the higher the ROE and profit retention, the higher the growth rate of a company compared to companies that don't necessarily bear these characteristics.
A Side By Side comparison of GenusPlus Group's Earnings Growth And 17% ROE
To begin with, GenusPlus Group seems to have a respectable ROE. Even when compared to the industry average of 15% the company's ROE looks quite decent. This certainly adds some context to GenusPlus Group's moderate 15% net income growth seen over the past five years.
As a next step, we compared GenusPlus Group's net income growth with the industry and were disappointed to see that the company's growth is lower than the industry average growth of 26% in the same period.
Earnings growth is an important metric to consider when valuing a stock. What investors need to determine next is if the expected earnings growth, or the lack of it, is already built into the share price. This then helps them determine if the stock is placed for a bright or bleak future. Is GenusPlus Group fairly valued compared to other companies? These 3 valuation measures might help you decide.
Is GenusPlus Group Efficiently Re-investing Its Profits?
GenusPlus Group's three-year median payout ratio to shareholders is 22% (implying that it retains 78% of its income), which is on the lower side, so it seems like the management is reinvesting profits heavily to grow its business.
Additionally, GenusPlus Group has paid dividends over a period of four years which means that the company is pretty serious about sharing its profits with shareholders. Upon studying the latest analysts' consensus data, we found that the company is expected to keep paying out approximately 21% of its profits over the next three years. However, GenusPlus Group's ROE is predicted to rise to 23% despite there being no anticipated change in its payout ratio.
Conclusion
Overall, we are quite pleased with GenusPlus Group's performance. Specifically, we like that the company is reinvesting a huge chunk of its profits at a high rate of return. This of course has caused the company to see a good amount of growth in its earnings. Having said that, looking at the current analyst estimates, we found that the company's earnings are expected to gain momentum. To know more about the company's future earnings growth forecasts take a look at this free report on analyst forecasts for the company to find out more.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 minutes ago
- Yahoo
3 European Stocks Estimated To Be Up To 47.2% Below Intrinsic Value
The European stock market has experienced a modest rise, buoyed by optimism surrounding potential trade agreements between the EU and the U.S., despite underlying economic uncertainties. In this environment, identifying undervalued stocks can present unique opportunities for investors seeking to capitalize on discrepancies between market prices and intrinsic values. Top 10 Undervalued Stocks Based On Cash Flows In Europe Name Current Price Fair Value (Est) Discount (Est) Westwing Group (XTRA:WEW) €9.20 €18.21 49.5% STMicroelectronics (ENXTPA:STMPA) €22.245 €43.94 49.4% RVRC Holding (OM:RVRC) SEK46.12 SEK91.42 49.5% Laboratorios Farmaceuticos Rovi (BME:ROVI) €55.55 €109.69 49.4% KebNi (OM:KEBNI B) SEK2.75 SEK5.43 49.4% Echo Investment (WSE:ECH) PLN5.36 PLN10.70 49.9% ATON Green Storage (BIT:ATON) €2.13 €4.22 49.5% Atea (OB:ATEA) NOK142.40 NOK282.80 49.6% adidas (XTRA:ADS) €198.95 €393.88 49.5% Absolent Air Care Group (OM:ABSO) SEK242.00 SEK482.63 49.9% Click here to see the full list of 197 stocks from our Undervalued European Stocks Based On Cash Flows screener. Here we highlight a subset of our preferred stocks from the screener. Lectra Overview: Lectra SA offers industrial intelligence solutions for the fashion, automotive, furniture markets, and other industries globally, with a market cap of €986.24 million. Operations: The company's revenue segments are distributed as follows: €176.26 million from the Americas, €134.84 million from the Asia-Pacific region, and €220.46 million from EMEA (Europe, Middle East, and Africa). Estimated Discount To Fair Value: 47.2% Lectra is trading at €25.95, significantly below its fair value estimate of €49.12, suggesting it is highly undervalued based on cash flows. The company's earnings are expected to grow 21.81% annually, outpacing the French market average of 12.7%. Recent strategic initiatives include the expansion of Lectra's Valia platforms into new markets and partnerships with companies like Edgecombe Furniture, enhancing operational efficiency and supporting future growth prospects through innovative solutions in manufacturing automation. Our growth report here indicates Lectra may be poised for an improving outlook. Navigate through the intricacies of Lectra with our comprehensive financial health report here. Pluxee Overview: Pluxee N.V. provides employee benefits and engagement solutions services across France, Latin America, Continental Europe, and internationally with a market cap of €2.72 billion. Operations: The company's revenue segments are comprised of €0.47 billion from Latin America, €0.24 billion from the Rest of the World, and €0.55 billion from Continental Europe. Estimated Discount To Fair Value: 45.4% Pluxee, trading at €18.69, is significantly undervalued with a fair value estimate of €34.21. Earnings grew by 182.1% last year and are projected to increase by 16.06% annually, surpassing the French market's growth rate of 12.7%. The company confirmed low double-digit revenue growth for fiscal years 2025 and 2026, supported by its resilient business model and strong performance in early fiscal 2025, indicating robust cash flow potential despite modest revenue growth forecasts of 7%. The analysis detailed in our Pluxee growth report hints at robust future financial performance. Click here and access our complete balance sheet health report to understand the dynamics of Pluxee. Vimian Group Overview: Vimian Group AB (publ) operates in the global animal health industry with a market capitalization of SEK19.52 billion. Operations: The company's revenue segments consist of Medtech (€142.10 million), Diagnostics (€22.50 million), Specialty Pharma (€178.20 million), and Veterinary Services (€61.60 million). Estimated Discount To Fair Value: 13.5% Vimian Group, trading at SEK36.7, is slightly undervalued with a fair value estimate of SEK42.45. The company's earnings grew by 132.6% last year and are expected to grow significantly over the next three years, outpacing the Swedish market's growth rate of 16.9%. Recent earnings reports show strong sales growth from EUR 91 million to EUR 104.3 million in Q2 2025, reflecting robust cash flow potential despite recent executive changes and low forecasted return on equity. Our expertly prepared growth report on Vimian Group implies its future financial outlook may be stronger than recent results. Unlock comprehensive insights into our analysis of Vimian Group stock in this financial health report. Turning Ideas Into Actions Take a closer look at our Undervalued European Stocks Based On Cash Flows list of 197 companies by clicking here. Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes. Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world. Searching for a Fresh Perspective? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ENXTPA:LSS ENXTPA:PLX and OM:VIMIAN. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
39 minutes ago
- Yahoo
European Dividend Stocks To Consider
The European stock market has shown tentative optimism recently, buoyed by potential trade deals with the U.S. and a stable interest rate environment as maintained by the European Central Bank. In this context, dividend stocks can be appealing to investors seeking steady income streams, especially when markets are navigating through uncertain economic landscapes. Top 10 Dividend Stocks In Europe Name Dividend Yield Dividend Rating Zurich Insurance Group (SWX:ZURN) 4.42% ★★★★★★ Rubis (ENXTPA:RUI) 7.20% ★★★★★★ OVB Holding (XTRA:O4B) 4.63% ★★★★★★ Les Docks des Pétroles d'Ambès -SA (ENXTPA:DPAM) 5.73% ★★★★★★ Holcim (SWX:HOLN) 4.76% ★★★★★★ HEXPOL (OM:HPOL B) 4.83% ★★★★★★ ERG (BIT:ERG) 5.15% ★★★★★★ DKSH Holding (SWX:DKSH) 4.00% ★★★★★★ Banque Cantonale Vaudoise (SWX:BCVN) 4.56% ★★★★★★ Allianz (XTRA:ALV) 4.51% ★★★★★★ Click here to see the full list of 229 stocks from our Top European Dividend Stocks screener. Below we spotlight a couple of our favorites from our exclusive screener. OPmobility Simply Wall St Dividend Rating: ★★★★★☆ Overview: OPmobility SE specializes in designing and producing intelligent exterior systems, customized complex modules, lighting systems, energy storage systems, and electrification solutions for global mobility players, with a market cap of €1.91 billion. Operations: OPmobility SE's revenue is primarily derived from its Exterior Systems segment (€4.70 billion), followed by Modules (€3.15 billion) and Powertrain (€2.62 billion). Dividend Yield: 5.4% OPmobility's dividend yield is among the top 25% in the French market, with a payout ratio of 32.2%, indicating dividends are well covered by earnings. Despite this, its dividend history has been volatile and unreliable over the past decade. Recent earnings showed a decline in net income to €90 million from €100 million year-on-year, reflecting potential challenges. The stock trades at a significant discount to estimated fair value but carries high debt levels and large one-off items affecting results. Get an in-depth perspective on OPmobility's performance by reading our dividend report here. According our valuation report, there's an indication that OPmobility's share price might be on the cheaper side. Eolus Aktiebolag Simply Wall St Dividend Rating: ★★★★☆☆ Overview: Eolus Aktiebolag (publ) focuses on the development, construction, and operation of renewable energy assets across several countries including Sweden, Finland, and the United States, with a market cap of SEK1.45 billion. Operations: Eolus Aktiebolag (publ) generates revenue through its activities in the renewable energy sector, which include developing, constructing, and managing energy assets in regions such as Poland, Spain, and the Baltic states. Dividend Yield: 3.9% Eolus Aktiebolag's dividend yield ranks in the top 25% of Swedish dividend payers, yet its history shows volatility and unreliability over the past decade. Despite a low payout ratio of 20.2%, dividends aren't supported by free cash flow or earnings, raising sustainability concerns. Recent financials reveal a significant revenue increase to SEK 2 billion but lower profit margins compared to last year. The stock trades at a notable discount to estimated fair value. Unlock comprehensive insights into our analysis of Eolus Aktiebolag stock in this dividend report. Our comprehensive valuation report raises the possibility that Eolus Aktiebolag is priced lower than what may be justified by its financials. Orell Füssli Simply Wall St Dividend Rating: ★★★★☆☆ Overview: Orell Füssli AG operates in security printing and technology, book retailing, and publishing across multiple regions including Switzerland, Germany, Europe, Africa, the Americas, Asia, and Oceania with a market cap of CHF205.80 million. Operations: Orell Füssli AG generates revenue through its operations in security printing and technology, book retailing, and publishing. Dividend Yield: 4.2% Orell Füssli's dividend yield is among the top 25% in Switzerland, supported by a payout ratio of 44.9%, indicating coverage by earnings and cash flows. Despite recent dividend increases, its short nine-year history reveals volatility and unreliability. Recent financials show strong growth with revenue reaching CHF 124.98 million and net income at CHF 6.69 million for H1 2025, suggesting improved profitability but future earnings are expected to decline slightly over the next three years. Delve into the full analysis dividend report here for a deeper understanding of Orell Füssli. In light of our recent valuation report, it seems possible that Orell Füssli is trading behind its estimated value. Seize The Opportunity Click through to start exploring the rest of the 226 Top European Dividend Stocks now. Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks. Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors. Searching for a Fresh Perspective? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ENXTPA:OPM OM:EOLU B and SWX:OFN. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Bloomberg
40 minutes ago
- Bloomberg
UBS Strategist Tantia Warns of Market Volatility in 2H
Suresh Tantia, Head CIO Asia Equity Strategy at UBS Global Wealth Management, shares his outlook on global markets in the second half of the year. Speaking with Paul Allen on Insight with Haslinda Amin, Tantia notes that investors could see near-term consolidation and profit-taking, driven by mounting uncertainty and shifting market dynamics. (Source: Bloomberg)
